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Abstract
Periampullary carcinoma is a malignancy that appears around the vatteri ampulla. This malignancy can 
originate from the pancreas, duodenum, and distal choledochal duct. Duodenal cancer is a very rare case, 
only about 0.3% of the gastrointestinal malignancies. Reported cases are increasing with the increasing use of 
esophagogastroduodenoscopy. The most frequently found carcinomas of the duodenum include adenocarcinoma, 
carcinoid, lymphoma, and leiomyosarcoma. The symptoms of these carcinomas are often not specific so the 
diagnosis is often late, leading to a poor prognosis. Early diagnosis and proper therapy provide a good prognosis. 
The case reported here representeda 52-year-old woman presented with hematemesis melena, anemia, jaundice, 
epigastric mass, right hypochondrial pain, and weight loss. From the esophagogastroduodenoscopy, the mass 
was found to obstruct half of the duodenum lumen and bleeding, which was easily triggered, was observed in the 
second part of the duodenum. CT scan revealed a mass in the head of the pancreas with gall bladder hydrops and 
obstruction of the intra and extra-hepatic billier system. After a Whipple operation Laparotomy, the histology 
showed papillary adenocarcinoma duodenum. Patients then underwen chemotherapy with 5 fluorouracil 
regimen. Patient's clinical condition is currently improving and no complaint is conveyed by the patient. 
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Abstrak
Karsinoma periampulari adalah keganasan yang muncul disekitar ampula vatteri. Keganasan dapat berasal 
dari pankreas, duodenum dan duktus koledokus bagian distal. Kanker duodenum kasus yang sangat jarang, 
sekitar 0,3% dari keganasan gastrointestinal. Laporan kasus meningkat seiring berkembangnya penggunaan 
esofagoduodenoskopi. Karsinoma duodenum yang sering dijumpai adenokarsinoma, disusul karsinoid, limfoma, 
dan leimiosarkoma. Gejala sering tidak spesifik sehingga diagnosis sering terlambat dan memberikan prognosis 
yang jelek. Diagnosis dini dan terapi yang tepat memberikan prognosis yang baik. Dilaporkan satu kasus wanita 
52 tahun, datang dengan hematemesis melena, anemia, jaundice, massa epigastrium, nyeri hipokhondrium 
kanan, dan penurunan berat badan. Pada esofagoduodenoskopi ditemukan massa memenuhi setengah lumen 
duodenum, mudah berdarah pada second part duodenum. CT Scan ditemukan massa di kaput pankreas dengan 
hidrops gall bladder serta obstruksi sistem billier intra dan ekstra hepatik. Dilakukan laparatomi Whipple’s 
operation, sitologi jaringan hasilnya papillari adenokarsinoma duodenum dan dilanjutkan kemoterapi dengan 
regimen 5 fluorourasil. Saat ini kondosi pasien membaik dan tidak ada keluhan.
Kata kunci: Adenokarsinoma, karsinoma duodenum periampulari, whipple
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Introduction 
Primary small intestinal malignancy is a very 
rare gastrointestinal malignancy.1,2 Duodenal 
carcinoma is more common than jejunum 
and ileum despite the fact it only contributes 
0.3% of gastrointestinal malignancies. This is 
because this carcinoma constitutes 50% of small 
intestinal malignancies.2 Several hypotheses are 
presented on the low incidence of malignancy 
in the small intestine when compared to the 
large intestine. These hypotheses include the 
followings: higher amount of liquid in the small 
intestine reduces irritation; short transit time in 
the small intestine reduces exposure to potential 
carcinogens; bacterial populations in the small 
intestine  produce less carcinogens; and high 
concentration of immunoglobulin A-producing 
lymphoid tissue also influences the incidence.3
The clinical manifestations of duodenal 
carcinoma are nonspecific that diagnosis is 
often unintentional and late. It is also difficult 
due to its rare incidence and non-typical 
clinical manifestations, which is worsened by 
the fact that  patients usually come with non-
specific symptoms without any indication for 
esophagogastroduodenoscopy.2,4,5 This delay in 
diagnosis makes it difficult to do resection of the 
primary lesions, leading to poorer prognosis. 
Although advances in diagnostic techniques 
has improved duodenal carcinoma detection, the 
unique anatomy of duodenum and the unreachable 
features of esophagogastroduodenoscopy limits 
the possibility of early diagnosis and curative 
resection in some patients. The prognostic factors 
in patients with duodenal carcinoma include 
total bilirubin, TNM stage, cytology, and direct 
management of cancer. Of all gastrointestinal 
malignancies, only 1% of deaths are caused by 
duodenal carcinomas.4,5 This is due to fact that 
duodenal adenocarcinoma patients often have 
poor prognosis due to late diagnosis when early 
diagnosis and the latest therapy will actually 
provide a good prognosis.6 This case report aims 
to describe the incidence and early diagnosis of 
periampullary duodenal carcinoma that enables 
early treatment and good prognosis.
Case
A 52-year-old Acehnese woman came to the 
hospital with a complaint of coffee-black 
vomiting and asphalt-like liquid feces with 
sticky consistency and foul-smell since 1 day 
before coming to the hospital. This condition 
was actually experienced by patients 2 weeks 
before this complaint and patient had received 
treatment for the first complaint. The patient 
also complained of yellowing in the eye that 
she observed since 2 months before the visit, 
which became more apparent 1 week before 
hospitalization. Patient also experienced 
brownish-yellow urination; pain in the upper 
right abdomen that was radiating to the back; 
decreased appetite since 1 month before 
hospitalization; and weight loss of 5 kg for the 
last 2 months.
Patient’s awareness at admission was compos 
mentis with normal hemodynamics. Physical 
examinations revealed anemia, jaundice, and 
an epigastric mass with a diameter of 5 cm with 
uneven surface and hard consistency as well as 
fixed and tender.
Laboratory test results presented a 
hemoglobin level of 7.0 g/dL, leukocyte count of 
9.200/mm³, hematocrit of 23%, platelet count 
of 277.000/mm3, blood sedimentation rate of 25 
mm/hour, peripheral hypochromic microcytic 
erythrocyte morphology, normal leukocyte 
count, normal platelet count, total bilirubin 
of 6.58 mg/dL, direct bilirubin of 5.12 mg/dL, 
aspartat aminotransferase (AST) of 189 u/L, 
alanin transaminase (ALT) of 175 u/L, alkaline 
phosphatase of 537 u/L, total protein of 4.5 g/
dL, albumin level of 3.4 g/dL, and globulin level 
of 1.1 g/dL. 
The chest X-rays showed normal thorax, 
heart, and lungs with no metastases. The patient 
underwent an esophagogastroduodenoscopy 
examination and a mass was found in the 
duodenum, which was then sent for biopsy. 
Esophagoduodenoscopy ImageFigure 1 
A mass was identified to occupy half of the 
lumen of the duodenum. This mass bled 
easily in the second part of the duodenum
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The Mass in the Head of the Pancreas 
with Gall Bladder Hydrops and 
Obstruction of the Intra- and Extra-
hepatobiliary System. The Alleged 
Mass was in the Ampulla of Vater
Figure 2
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The result of biopsy showed mild dysplasia 
and inflammation. Diagnosis of  periampullary 
duodenal carcinoma was then made based on 
the anamnesis, physical examination results, 
and supporting examination results in the form 
of esophagogastroduodenoscopy biopsy and 
abdominal computed tomography (CT) scan 
results.
Patient management at admission consisted 
of bed rest, soft diet, concentrated red blood 
transfusion, intravenous proton pump inhibitor 
(PPI) provision, and mucosa protector provision. 
After a discussion with the digestive surgeon, a 
whipple operation laparotomy was performed 
on the patient. The laparotomy revealed a 
mass in the duodenum, with a size of 8x6 cm, 
that involved 2 lymph nodes. Tissue cytology 
examination result presented that this was 
papillary adenocarcinoma of the duodenum. 
After surgery and biopsy, diagnosis was 
established as stage III periampullary duodenal 
carcinoma (T4 N1 M0) and a regimen consisting 
of twelve 5-fluorouracil therapy was performed. 
After finishing the chemotherapy, patient’s 
clinical condition was good. 
Discussion
Duodenal carcinoma often occurs in the sixth 
decade and rarely occurs under the age of 
50 years with more women experience this 
condition than men (3:2). Duodenal malignancy 
is very rare with the third and fourth parts of 
the duodenum as the most frequent parts to 
be affected (approximately 45%). This is then 
followed by the second part (40%) and the 
first part of the duodenum (15%).4 In this case 
study, a case involving a 52-year-old female 
patient with carcinoma in the second part of the 
periampullary duodenum is described.
Duodenal carcinoma is very rare, so the 
correct diagnosis is often late.7–9 Duodenal 
carcinoma is also often asymptomatic, which 
contributes to the delay in diagnosis. This 
asymptomatic nature is due to the ability of the 
intestinal wall to distend, as well as the presence 
of natural fluid content in the intestinal cavity.8 
Carcinoma of the duodenum must be considered 
in conditions with unexplainable recurrent 
abdominal pain and intestinal obstruction, 
especially if no inflammatory bowel disease is 
found or there is no history of previous surgeries. 
This condition should also be suspected when 
there is intussusception in adults and chronic 
intestinal bleeding.4
The manifestations of small intestinal 
adenocarcinoma are very dependent on the 
location of the lesion. Lesions in the duodenum 
are reflected as symptoms of intestinal 
obstruction that includes both real and subtle 
gastrointestinal bleeding, abdominal pain, and 
biliary obstruction.7,8 The most frequent clinical 
manifestations of duodenal carcinoma initially 
begin with intermittent abdominal pain (67.4%), 
intraabdominal mass (31.2%), intestinal 
obstruction (24.1%), hematochezia (21.3%), 
jaundice (16.3%), fever (14.2%), accompanied 
by intestinal perforation and peritonitis (5.7%), 
upper gastrointestinal bleeding and shock (5%), 
and intraabdominal bleeding (1.4%).9 Other 
symptoms are loss of appetite, diarrhea, anemia, 
and weight loss. Symptoms appear from 0 to 
41 months, but the most common is around 2 
months. In a previous study involving 65 cases, 
the diagnosis is marked by intermittent pain in the 
abdomen and accompanied by biliary vomiting.4 
Large lesions will lead to symptoms of about 70% 
obstruction such as periumbilical pain, bloating, 
nausea and vomiting. Complaints of back pain 
in primary duodenal carcinoma patients are 
associated with retroperitoneal spread while 
the back pain mechanisms are associated with 
tumor bleeding, invasion of enteric ganglia, and 
serious involvement. Gastrointestinal bleeding 
is the second most common symptom in benign 
lesions (20–50%) but is less common in severe 
conditions. Periampullary lesions will give 
symptoms of jaundice or pancreatitis.5 In the 
reported case, the patient gave symptoms of 
gastrointestinal bleeding for 2 weeks, jaundice 
Majalah Kedokteran Bandung, Volume 53 No. 1, March 202160
D Maghfirah et al: Rare Case of Periampullary Duodenal Carcinoma
for 2 months that became more apparent 1 week 
before hospitalization, right hypochondrial pain, 
decreased appetite, and 5 kg weight loss during 
the last 2 months.
Physical examination results of duodenal 
carcinoma are not specific, but in more than 25% 
of cases, a palpable abdominal mass was observed. 
Signs of obstruction are distention, borborygmi, 
palpable mass, and abdominal muscle stiffness. 
Fecal blood is found in 10–70% while some 
patients experience secondary jaundice that can 
be caused by a biliary obstruction or due to liver 
metastasis. In an advanced stage of disease with 
metastases, cachexia, hepatomegaly, and ascites 
can be found.3,4 On physical examination of the 
patient in this case study, anemia, jaundice, and 
epigastric mass with a diameter of 5 cm with 
uneven surface and hard consistency that is fixed 
and tender are identified.  
The results of laboratory tests at an early stage 
are not specific, which may explain the delayed 
diagnosis. Gastrointestinal bleeding can give a 
picture of iron deficiency anemia. The duodenal 
lesions that block the biliary system will increase 
alkaline phosphatase and serum bilirubin.8 On 
laboratory examination of the patient in this 
case study, microcytic hypochromic anemia was 
found due to chronic occult bleading, along with 
an increase in serum bilirubin with obstruction, 
and an increase in alkaline phosphatase. In the 
case of the masses, the ampulla vater had been 
urged, causing biliary obstruction.
It is difficult to use radiological examination 
results to distinguish between duodenal 
carcinoma, chronic duodenal ulcer, and Crohn’s 
disease in patients with chronic enteritis.7 A 
plain abdominal radiograph is rarely useful 
to see the location of the small intestine mass 
but will provide benefits to examine suspected 
intestinal obstruction or perforation. In 50–80% 
of patients with small intestinal carcinoma, small 
intestinal follow-through shows an abnormality. 
Barium enema will show a lesion in the terminal 
ileum if there is barium reflux in the ileocaecal 
valve. Video capsule endoscopy (VCE) can 
detect a small intestinal mass, especially if 
it cannot be reached by regular enteroscopy 
examination. Further more, several studies have 
mentioned that VCE is superior to enteroclysis, 
enteroscopy, colonoscopy, and CT scan. Double-
balloon endoscopy can also evaluate small 
bowel mass but is preferred for tissue biopsy 
and for interventions such as coagulation for 
lesion bleeding and polypectomy. CT scans with 
the latest modalities can provide a good tumor 
picture. Other modalities that can be used are 
endoscopic ultrasonography and angiography.3,6 
Frequently used diagnostic techniques are 
abdominal ultrasonography, followed by 
abdominal computed tomography, upper 
gastrointestinal radiography, and endoscopy. 
Other techniques include endoscopic retrograde 
cholangiopancreatography (ERCP), superior 
mesenteric arteriography, colonoscopy, and 
bone scanning.9 Endoscopic biopsy diagnoses 
many malignant duodenal tumors before surgery 
with the more distal a tumor more difficult to 
diagnose before surgery. The accuracy of CT 
scans in enforcing duodenal adenocarcinoma 
staging is around 47–61%, which is merely 
used to detect mesenteric infiltration and 
regional lymphadenopathy.2 The diagnosis is 
best made using esophagogastroduodenoscopy 
and biopsy.3,4 Esophagogastroduodenoscopy 
with biopsy leads to a definitive diagnosis. If 
the diagnosis is still doubtful, a CT scan of the 
abdomen can be done to see the malignancy in 
the duodenal wall and to identify the stage of 
the malignancy. However, it should be noted that 
the diagnostic accuracy of abdominal CT scan in 
duodenal malignancies with masses smaller than 
2 cm is not optimum, with a sensitivity of 94% 
and a specificity of 82%.4 In the case reported in 
this case study, an esophagogastroduodenoscopy 
and biopsy examination was performed on 
the patient and the result demonstrated the 
presence of a mass in the second part of the 
duodenum that occupied half the intestinal 
lumen of duodenal carcinoma. On the CT scan of 
the abdomen, a mass on the head of the pancreas 
with gall bladder hydrops and obstruction of 
the intra and extra-hepatobiliary system was 
also identified. There was also a suspected mass 
in the ampulla Vater. Therefore, a diagnosis of 
a duodenal carcinoma that urges the biliary 
system was made. On chest X-ray, no metastasis 
was found. 
The management of duodenal carcinoma 
is based on the histopathology type, location, 
and area. In duodenal carcinoma, the main 
therapy is tumor resection, which is successful 
in 40–65% of cases.9,10 The main choice is 
pancreaticoduodenectomy, or known as the 
Whipple procedure. In a retrospective study 
aimed at looking at the results of the primary 
duodenal adenocarcinoma curative surgery, 
different types of surgery were compared 
with 32 patients underwent laparotomy, 18 
underwent pancreaticoduodenectomy (Whipple 
procedure), 6 underwent segmental resections, 
and 8 underwent bypass procedures. The results 
demonstrated that the 5-year survival rate 
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in the Whipple operation is 27.8%, while the 
survival rate in segmental resection is 16.7%, 
showing no significant difference between the 
two procedures. Whipple operation is the first 
choice in malignant adenocarcinoma in the 
first and second parts of the duodenum, and 
segmental resection is useful in distal duodenal 
tumors.6,11 Pancreaticoduodenectomy (Whipple 
procedure) is a curative surgery and therapeutic 
option for tumors located in the first and second 
parts of the duodenum, giving a better prognosis 
than in duodenal resection.2,9,11,12 Laparotomy 
is performed for resection and anastomosis of 
the affected part with a limit of 10 centimeters 
proximal and distal, including the mesentery 
and lymph nodes. If curative resection is not 
possible, palliative resection can be performed 
with anastomose or stoma. The next option 
Is that the affected part can be bypassed so 
it will not give the symptoms of obstruction. 
With the development of endoscopic expertise 
and instruments, resection of submucous 
carcinoma in situ can be done with double-
balloon endoscopy. Cytoreduction surgery 
(parietal peritonectomy) and Hemomycin C and 
5-fluorouracil chemotherapy can be performed 
on extensive local duodenal carcinoma, with a 
life expectancy of 12 to 40 months after surgery.5
Chemotherapy is useful for masses that 
cannot be resected or for patients who are at 
high risk for recurrence, such as patients who 
have regional lymph node involvement. This 
is important to increase life expectancy. The 
role of adjuvant chemotherapy in duodenal 
adenocarcinoma is still unclear, Several 
studies have shown its important benefits in 
increasing life expectancy.1,13,14 Patients who 
have undergone curative surgery 50–60% 
survive more than 5 years. In some studies 
it is said that chemotherapy is performed on 
masses that cannot be resected. The mass 
is reduced so that it can be resected, which 
increases life expectancy. Chemotherapy can use 
5-fluorouracil, capecitabine, and oxaliplatin, but 
the most commonly used and moar beneficial 
5-fluorouracil. Recent data shows that the use of 
5-fluorouracil as an adjuvant chemotherapy, as 
well as capecitabine and irinotecan for palliative 
chemotherapy, presents very good results.1,4,13,14 
For the patient in this case study,  laparotomy 
was performed based on indications of duodenal 
carcinoma. A mass in the duodenum with a size 
of 8x6 cm with the involvement of 2 lymph nodes 
was found. Whipple procedure was performed, 
followed by adjuvant chemotherapy with 
5-fluorouracil twelve times.
The stage of this adenocarcinoma is determined 
based on the seventh edition American Joint 
Committee on Cancer which follows the TNM 
staging system. For the T, Tx is assigned if the 
primary tumor cannot be explained; T0 if the 
primary tumor is absent; Tis if the tumor is in 
situ; T1 if the tumor invades the lamina propria 
(T1a) and submucosa (T1b); T2 if the tumor 
invades muscle; T3 if the tumor invades muscle, 
subserosa, mesentery, or retroperitoneum with 
a size of less than 2 centimeters wide; and T4 
if the tumor has penetrated the peritoneum 
and invades other organ structures, such as the 
pancreas. Meanwhile, for the N, Nx is assigned 
when the lymph node involvement cannot be 
explained; N0 when it does not involve regional 
lymph nodes; N1 when it touches 1–3 regional 
lymph nodes; and N2 if there is metastasis in 
four or more regional lymph nodes. The M is 
categorized as follows: Mx if there is inexplicable 
distant metastases; M0 if there is no far distant 
metastasis; and M1 if there is distant metastasis. 
Stages are then determined as follows: stage 0 for 
Tis N0 M0; stage I for T1 N0 M0, T2 N0 M0; Stage 
II for T3 N0 M0, T4 N0 M0; stage III for T0-4 N1 
M1; and stage IV for T 0-4 N 0-2 M1.15 In this case 
study, tumors had invaded the pancreas with the 
involvement of two regional lymph nodes and no 
distant metastasis, showing that the stage of the 
adenocarcinoma was stage III-T4 N1 M0.
Primary duodenal cancer is the most 
common adenocarcinoma (around 50%) and 
often occurs in distal duodenum and proximal 
jejunum.7 In a retrospective study on the clinical-
pathological analysis of duodenal carcinoma, 
histopathological examinations were performed. 
Histopathological examination of duodenal 
carcinoma is important to see the correct 
histological subtypes.16,17 All patients were 
diagnosed histopathologically after surgery. 
In a study of 141 patients, 61 (43.3%) are 
found to have adenocarcinoma, 28 (19.8%) suffer 
from gastrointestinal stromal tumor  (GIST), 
17 (12.1%) suffer from carcinoid, 14 (9.9%) 
suffer from malignant lymphoma, 10 (7.1%) 
suffer from leiomyosarcoma, 6 (4.3%) suffer 
from malignant melanoma, 3 (2.1%) suffer from 
malignant neurilemmoma, and 2 (1.4%) suffer 
from fibrosarcoma. Metastatic lymphadenopathy 
is unexpectedLy found during curative resection 
surgery in around 37.7%.9 Patient in this case 
study was found to have duodenal papillary 
adenocarcinoma.
Although chemotherapy has progressed, the 
prognosis of patients with duodenal carcinoma is 
very much dependent on the stage at diagnosis. 
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If the diagnosis is established early, patients still 
have a chance for resection as the main treatment 
choice. However, 58% of patients with duodenal 
carcinoma are diagnosed at an advanced stage 
(III and IV).2,13,18,19 The prognosis of duodenal 
adenocarcinoma is usually poor, with curative 
resection increases the 5-year life expectancy 
from 0% to 54%. Patients without lymph node 
involvement during surgery has increased 5-year 
life expectancy of 63%. The discovery of anemia 
at the beginning of the diagnosis dramatically 
increases life expectancy; this is associated with 
diagnosis at an early stage.9,13,14,19,20
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